The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|1 Dec 2015||Submitted||Original manuscript|
|11 Mar 2016||Reviewed||Reviewer Report - Shetty Ravi Dyavar|
|3 Apr 2016||Reviewed||Reviewer Report - Godwin Nchinda|
|18 Apr 2016||Author responded||Author comments - Kristin Brekke|
|Resubmission - Version 2|
|18 Apr 2016||Submitted||Manuscript version 2|
|16 Aug 2016||Reviewed||Reviewer Report - Michael Grant|
|19 Aug 2016||Reviewed||Reviewer Report - Catarina E. Hioe|
|28 Oct 2016||Author responded||Author comments - Kristin Brekke|
|Resubmission - Version 3|
|28 Oct 2016||Submitted||Manuscript version 3|
|30 Jan 2017||Reviewed||Reviewer Report - Catarina E. Hioe|
|23 Feb 2017||Author responded||Author comments - Kristin Brekke|
|Resubmission - Version 4|
|23 Feb 2017||Submitted||Manuscript version 4|
|8 Mar 2017||Editorially accepted|
|24 Mar 2017||Article published||10.1186/s12879-017-2316-x|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.